H3; 81 - device evaluation is not necessary because the reported event(s) have been determined as not related to vns therapy.Livanova usa, inc.Submits this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation, based on information that livanova has obtained, but may not have been able to investigate or verify prior to the date the report was required by the fda.This report does not constitute an admission, or a conclusion by fda or anyone else, that the device, livanova, or livanovas employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any defects¿ or malfunctions¿.These words are incorporated into the fda 3500a medwatch form by the fda, and livanova objects to their use.
|
It was reported that following a generator replacement, the patient developed swelling and an infection at the generator site.The surgeon prescribed medication, but the infection persisted.It was noted from the patients mother that the patient had developed a seroma and that the incision never fully closed; the lead was also exposed.In addition, the neurologist noted that they have been able to program the vns and make adjustments.An update was provided that the patient underwent a full system explant due to the infection.Device history records were reviewed for the generator and lead.The generator and lead passed all specifications prior to distribution.The generator and lead were hp sterilized.No additional relevant information has been received to date.
|